Chuanbing Shi
- Molecular Medicine top 5%
-
- Cancer, Hypoxia, and Metabolism 3
-
- Heat shock proteins research 3
- Connexins and lens biology 2
-
- Microtubule and mitosis dynamics 2
-
- Renal cell carcinoma treatment 3
- Gastric Cancer Management and Outcomes 3
-
- Cancer Immunotherapy and Biomarkers 3
-
- Liver Disease Diagnosis and Treatment 2
- Co-authors
- Hao WenBaolin WangJie WangZhenyu HeNing HouPingsheng ChenXiaojun YangXiaodong Bu
- Journals
- Scientific Reports (1 paper)Biochemical and Biophysical Research Communications (1 paper)Cancer Letters (1 paper)
- Partner nations
- ChinaBangladesh
In The Last Decade
Chuanbing Shi
19 papers receiving 429 citations
Peers
Comparison fields: 5 of 66
- Molecular Medicine 147
- Cancer Research 61
- Molecular Biology 253
- Pharmacology 56
- Cell Biology 43
Countries citing papers authored by Chuanbing Shi
This map shows the geographic impact of Chuanbing Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuanbing Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuanbing Shi more than expected).
Fields of papers citing papers by Chuanbing Shi
This network shows the impact of papers produced by Chuanbing Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuanbing Shi. The network helps show where Chuanbing Shi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chuanbing Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 6 | |
| 6 | 2021 | 3 | |
| 7 | 2019 | 6 | |
| 8 | 2019 | 15 | |
| 9 | Prognostic value of carbonic anhydrase XII (CA XII) overexpression in hepatocellular carcinoma. | 2019 | 7 |
| 10 | 2017 | 14 | |
| 11 | 2017 | 40 | |
| 12 | 2017 | 5 | |
| 13 | 2016 | 9 | |
| 14 | 2015 | 23 | |
| 15 | 2014 | 23 | |
| 16 | Alpha B-crystallin correlates with poor survival in colorectal cancer. | 2014 | 22 |
| 17 | High expression of inositol polyphosphate phosphatase-like 1 associates with unfavorable survival in hepatocellular carcinoma. | 2013 | 23 |
| 18 | 2012 | 7 | |
| 19 | 2011 | 210 | |
| 20 | 2010 | 8 |
About Chuanbing Shi
Chuanbing Shi is a scholar working on Cancer Research, Gastroenterology and Nephrology, having authored 22 papers that have together received 441 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Gastric Cancer Management and Outcomes (3 papers), Heat shock proteins research (3 papers), Liver Disease Diagnosis and Treatment (2 papers), Connexins and lens biology (2 papers) and Microtubule and mitosis dynamics (2 papers). The work is most often cited by research in Molecular Medicine (147 citations), Cancer Research (61 citations) and Molecular Biology (253 citations). Chuanbing Shi has collaborated with scholars based in China and Bangladesh. Frequent co-authors include Hao Wen, Baolin Wang, Jie Wang, Zhenyu He, Ning Hou, Pingsheng Chen, Xiaojun Yang, Xiaodong Bu, Xuefeng Gu and Lin Xiong. Their work appears in journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.